MENU
GNMSF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Genmab A/S (GNMSF) Ownership - Who owns Genmab A/S?
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more
Profile
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.11B
P/E Ratio
12.64
Total Cash
2.9B
Projected Growth
2.31
Total Debt
148M
Revenue
3.26B
Risk (Beta)
0.98
Dividend Yield
N/A
Total Cash/Share
47.13
Total Debt/Equity
N/A
Revenue/Share
51.43 USD as % of share price
Fundamentals
GNMSF
Capitalization
15.1B
P/E Ratio
12.64
Risk (Beta)
0.98
Dividend Yield
N/A
Total Cash
2.9B
Total Cash/Share
47.13
Total Debt
148M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
2.31
Revenue/Share (as % of the share price)
51.43%
Revenue
3.26B
ROE
N/A
Book Value
5.3B
P/B Ratio
2.83
Cash Flow
N/A
Earnings
19.43
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10M
Current Ratio
6.22
Current Revenue Per Employee
350644.44
Dividends Per Share - Security
N/A
EBITDA
1.48B
Float
N/A
Float - Current
N/A
Gross Income Margin
93.84
Revenue To Assets
20.49
Shares Held By Institutions
18.8B
Shares Outstanding - Current
61.5M
Total Liabilities
1.16B
Total Volume MTD
N/A
Value
N/A
Gain YTD
17.827
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com